Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 402-170-5 | CAS number: 106359-91-5 C.I. REACTIVE YELLOW 174; GIALLO REATTIVO 174; JAUNE REACTIF 174; REAKTIV GELB 174
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- basic assessment basis of physicochemical properties and toxicological studies.
- Type of information:
- other: basic assessment basis of physicochemical properties and toxicological studies.
- Adequacy of study:
- key study
- Study period:
- 28 January 2021
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- accepted calculation method
Data source
Reference
- Reference Type:
- other: Basic assessment
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- basic assessment basis of physicochemical properties and toxicological studies.
- GLP compliance:
- no
Test material
- Reference substance name:
- Trisodium 7-(4-(4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine- 2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
- EC Number:
- 402-170-5
- EC Name:
- Trisodium 7-(4-(4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine- 2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
- Cas Number:
- 106359-91-5
- Molecular formula:
- C26H26FN9O13S4.3Na
- IUPAC Name:
- trisodium 7-{2-[2-(carbamoylamino)-4-{[4-({2-[2-(ethenesulfonyl)ethoxy]ethyl}amino)-6-fluoro-1,3,5-triazin-2-yl]amino}phenyl]diazen-1-yl}naphthalene-1,3,6-trisulfonate
- Details on test material:
- Name: FAT 40224/H TE
Batch No.: TZ 2382-BB-503C81
Physical State: powder
Colour: red
Density: 1.46 g/cm3 (20°C)
pH: 6.5 to 7.5 conc.(% w/w): 1%
Melting Point: > 200°C
Purity / Active Components: sum of all coloured substances: 85.4%, main constituents: 50.6%
Date of Analysis: 23.07.2012
Storage Conditions: at room temperature
Expiry Date: 28.01.2017
Constituent 1
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Oral/gastrointestinal absorption:
Based on the molecular weight of 885.75 g/mol for Reactive Yellow 174, it can be assumed to have low oral absorption. However, with high water solubility of 341 g/L, Reactive Yellow 174 may readily dissolve into the gastrointestinal fluids and may get absorbed via passive diffusion. Furthermore, in an acute oral toxicity study, no mortality or treatment related effects were observed, while, in the 28-days repeated dose oral toxicity study, no treatment related effects on mortality, clinical signs, food consumption, body weight, ophthalmoscopic examinations, clinical laboratory investigations and pathology were seen up to highest dose group. In the reproductive and developmental toxicity screening test, discoloured yellow testes (2/10 high dose males) and discoloured yellow oviduct and cervix (2/10 high dose females) were observed during the gross pathological examination. In addition, histologically, in male rats, yellow-brown pigment in interstitial macrophages was seen at a minimal or mild degree in the testis and at a minimal degree in the epididymis in all rats treated at 1000 mg/kg/day. These finding suggests that Reactive Yellow 174 may get absorbed to an extent when administered via oral route.
Dermal absorption:
The molecular weight (885.75 g/mol) for Reactive Yellow 174, indicates it being too large for dermal absorption. With high solubility in water (341 g/L) and low partition coefficient (<-10.8), dermal uptake is expected to be low as Reactive Yellow 174 considered to be too hydrophilic to cross the lipid rich environment of the stratum corneum. In the acute dermal toxicity study at 2000 mg/kg bw, female rats showed emaciation during the study, indicating absorption of the test substance by the dermal route. Reactive Yellow 174 was neither corrosive nor irritating to the skin as well as eyes. Reactive Yellow 174 (FAT 40224/C) lead to two deaths in the Guinea pig maximization test. The animal which died on day 6 after dermal injection with Reactive Yellow 174, was found to have yellowish lung during the necropsy. The second animal (vehicle control) died on day 37, after receiving Reactive Yellow 174 as dermal application, also had yellowish contents in the small intestine. These findings suggest that dermal exposure will lead to absorption at some levels. Thus, taking into account the findings from the acute dermal toxicity study, skin sensitization study and the reproduction and developmental toxicity screening test as discussed under oral absorption section, Reactive Yellow 174 is expected to get absorbed to some extent via dermal route.
Respiratory absorption:
No experimental data is available concerning the respiratory absorption of Reactive Yellow 174. However, high water solubility (341 g/L), indicates if dust is produced will get trapped in the mucus. However, very hydrophilic substances can be transported out of the respiratory tract, when molecular weights are larger than 200. Furthermore, the low partition coefficient (<-10.8) and hydrophilicity will further limit the respiratory absorption. However, as seen with oral and dermal routes, absorption via respiratory exposure may take place to a limited extent. - Details on distribution in tissues:
- Systemic distribution due to high water solubility would most likely occur via the serum. Owing to the high molecular size and hydrophilic nature of the substance (low n-octanol/water partition coefficient and high water solubility), access of Reactive Yellow 174 to the central nervous system (CNS) or testes is likely to be restricted by the blood-brain and blood-testes barriers, while accumulation in body fat is unlikely to occur.
- Details on excretion:
- Route of excretion for Reactive Yellow 174 has not been investigated. However, owing to the hydrophilic nature of the substance, it will be expected to be predominantly excreted via urine, while any unabsorbed remaining fraction being excreted in the feces.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Currently no investigation regarding metabolism of Reactive Yellow 174 is available. Moreover, in the genetic toxicity studies with Reactive Yellow 174, there was no evidence to indicate Reactive Yellow 174 or metabolite influenced hepatic metabolism. However, as seen with the toxicity studies, Reactive Yellow 174 did lead to discoloration of internal organs (testes, oviduct, cervix, etc.), limited metabolism is expected to occur. However, the high-water solubility of Reactive Yellow 174 suggests that metabolism would be limited and not required to facilitate renal excretion.
Applicant's summary and conclusion
- Conclusions:
- Based on the above discussion, it can be concluded that Reactive Yellow 174 would have some degree of absorption via oral, dermal and inhalation exposure. Systemic distribution would most likely occur via the serum, while metabolism is expected to occur but would be limited and not required to facilitate renal excretion.
- Executive summary:
Absorption
Oral/gastrointestinal absorption:
Based on the molecular weight of 885.75 g/mol for Reactive Yellow 174, it can be assumed to have low oral absorption. However, with high water solubility of 341 g/L, Reactive Yellow 174 may readily dissolve into the gastrointestinal fluids and may get absorbed via passive diffusion. Furthermore, in an acute oral toxicity study, no mortality or treatment related effects were observed, while, in the 28-days repeated dose oral toxicity study, no treatment related effects on mortality, clinical signs, food consumption, body weight, ophthalmoscopic examinations, clinical laboratory investigations and pathology were seen up to highest dose group. In the reproductive and developmental toxicity screening test, discoloured yellow testes (2/10 high dose males) and discoloured yellow oviduct and cervix (2/10 high dose females) were observed during the gross pathological examination. In addition, histologically, in male rats, yellow-brown pigment in interstitial macrophages was seen at a minimal or mild degree in the testis and at a minimal degree in the epididymis in all rats treated at 1000 mg/kg/day. These finding suggests that Reactive Yellow 174 may get absorbed to an extent when administered via oral route.
Dermal absorption:
The molecular weight (885.75 g/mol) for Reactive Yellow 174, indicates it being too large for dermal absorption. With high solubility in water (341 g/L) and low partition coefficient (<-10.8), dermal uptake is expected to be low as Reactive Yellow174 considered to be too hydrophilic to cross the lipid rich environment of the stratum corneum. In the acute dermal toxicity study at 2000 mg/kg bw, female rats showed emaciation during the study, indicating absorption of the test substance by the dermal route. Reactive Yellow 174 was neither corrosive nor irritating to the skin as well as eyes. Reactive Yellow 174 (FAT 40224/C) lead to two deaths in the Guinea pig maximisation test. The animal which died on day 6 after dermal injection with Reactive Yellow 174, was found to have yellowish lung during the necropsy. The second animal (vehicle control) died on day 37, after receiving Reactive Yellow 174 as dermal application, also had yellowish contents in the small intestine. These findings suggest that dermal exposure will lead to absorption at some levels. Thus, taking into account the findings from the acute dermal toxicity study, skin sensitisation study and the reproduction and developmental toxicity screening test as discussed under oral absorption section, Reactive Yellow 174 is expected to get absorbed to some extent via dermal route.
Respiratory absorption:
No experimental data is available concerning the respiratory absorption of Reactive Yellow 174. However, high water solubility (341 g/L), indicates if dust is produced will get trapped in the mucus. However, very hydrophilic substances can be transported out of the respiratory tract, when molecular weights are larger than 200. Furthermore, the low partition coefficient (<-10.8) and hydrophilicity will further limit the respiratory absorption. However, as seen with oral and dermal routes, absorption via respiratory exposure may take place to a limited extent.
Distribution
Systemic distribution due to high water solubility would most likely occur via the serum. Owing to the high molecular size and hydrophilic nature of the substance (low n-octanol/water partition coefficient and high water solubility), access of Reactive Yellow 174 to the central nervous system (CNS) or testes is likely to be restricted by the blood-brain and blood-testes barriers, while accumulation in body fat is unlikely to occur.
Metabolism
Currently no investigation regarding metabolism of Reactive Yellow 174 is available. Moreover, in the genetic toxicity studies with Reactive Yellow 174, there was no evidence to indicate Reactive Yellow 174 or metabolite influenced hepatic metabolism. However, as seen with the toxicity studies, Reactive Yellow 174 did lead to discoloration of internal organs (testes, oviduct, cervix, etc.), limited metabolism is expected to occur. However, the high-water solubility of Reactive Yellow 174 suggests that metabolism would be limited and not required to facilitate renal excretion.
Excretion
Route of excretion for Reactive Yellow 174 has not been investigated. However, owing to the hydrophilic nature of the substance, it will be expected to be predominantly excreted via urine, while any unabsorbed remaining fraction being excreted in the feces.
CONCLUSION
Based on the above discussion, it can be concluded that Reactive Yellow 174 would have some degree of absorption via oral, dermal and inhalation exposure. Systemic distribution would most likely occur via the serum, while metabolism is expected to occur but would be limited and not required to facilitate renal excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.